2nd Quarter - Report
BALLARD PARTNERS for NOVO NORDISK INC.
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Guidance regarding pharmaceutical regulations.
Foreign entity interest: Novo Nordisk A/S, Novo Holdings A/S, and Novo Nordisk Fondation, as parent companies of Novo Nordisk Inc., identified on the LD-1 report, have indirect interests in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BALLARD | — |
| SYLVESTER LUKIS | — |
| MONICA RODRIGUEZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.